107 related articles for article (PubMed ID: 22524686)
21. Changes of NK cells in preeclampsia.
Fukui A; Yokota M; Funamizu A; Nakamua R; Fukuhara R; Yamada K; Kimura H; Fukuyama A; Kamoi M; Tanaka K; Mizunuma H
Am J Reprod Immunol; 2012 Apr; 67(4):278-86. PubMed ID: 22364232
[TBL] [Abstract][Full Text] [Related]
22. Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta.
Westgaard IH; Berg SF; Vaage JT; Wang LL; Yokoyama WM; Dissen E; Fossum S
J Leukoc Biol; 2004 Dec; 76(6):1200-6. PubMed ID: 15356098
[TBL] [Abstract][Full Text] [Related]
23. Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists.
Gorski KS; Waller EL; Bjornton-Severson J; Hanten JA; Riter CL; Kieper WC; Gorden KB; Miller JS; Vasilakos JP; Tomai MA; Alkan SS
Int Immunol; 2006 Jul; 18(7):1115-26. PubMed ID: 16728430
[TBL] [Abstract][Full Text] [Related]
24. Cyclosporin A regulates human NK cell apoptosis induced by soluble HLA-I or by target cells.
Poggi A; Zocchi MR
Autoimmun Rev; 2005 Nov; 4(8):532-6. PubMed ID: 16214091
[TBL] [Abstract][Full Text] [Related]
25. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.
Pende D; Rivera P; Marcenaro S; Chang CC; Biassoni R; Conte R; Kubin M; Cosman D; Ferrone S; Moretta L; Moretta A
Cancer Res; 2002 Nov; 62(21):6178-86. PubMed ID: 12414645
[TBL] [Abstract][Full Text] [Related]
26. Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors.
Ortaldo JR; Mason AT; Mason LH; Winkler-Pickett RT; Gosselin P; Anderson SK
J Immunol; 1997 Feb; 158(3):1262-7. PubMed ID: 9013968
[TBL] [Abstract][Full Text] [Related]
27. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.
El-Sherbiny YM; Meade JL; Holmes TD; McGonagle D; Mackie SL; Morgan AW; Cook G; Feyler S; Richards SJ; Davies FE; Morgan GJ; Cook GP
Cancer Res; 2007 Sep; 67(18):8444-9. PubMed ID: 17875681
[TBL] [Abstract][Full Text] [Related]
28. Membrane-associated heparan sulfate proteoglycans are involved in the recognition of cellular targets by NKp30 and NKp46.
Bloushtain N; Qimron U; Bar-Ilan A; Hershkovitz O; Gazit R; Fima E; Korc M; Vlodavsky I; Bovin NV; Porgador A
J Immunol; 2004 Aug; 173(4):2392-401. PubMed ID: 15294952
[TBL] [Abstract][Full Text] [Related]
29. NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans.
Parodi M; Favoreel H; Candiano G; Gaggero S; Sivori S; Mingari MC; Moretta L; Vitale M; Cantoni C
Front Immunol; 2019; 10():719. PubMed ID: 31024551
[TBL] [Abstract][Full Text] [Related]
30. Multiple receptors trigger human NK cell-mediated cytotoxicity against porcine chondrocytes.
Sommaggio R; Cohnen A; Watzl C; Costa C
J Immunol; 2012 Mar; 188(5):2075-83. PubMed ID: 22287712
[TBL] [Abstract][Full Text] [Related]
31. Recognition and prevention of tumor metastasis by the NK receptor NKp46/NCR1.
Glasner A; Ghadially H; Gur C; Stanietsky N; Tsukerman P; Enk J; Mandelboim O
J Immunol; 2012 Mar; 188(6):2509-15. PubMed ID: 22308311
[TBL] [Abstract][Full Text] [Related]
32. A new self: MHC-class-I-independent natural-killer-cell self-tolerance.
Kumar V; McNerney ME
Nat Rev Immunol; 2005 May; 5(5):363-74. PubMed ID: 15841099
[TBL] [Abstract][Full Text] [Related]
33. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
Diefenbach A; Hsia JK; Hsiung MY; Raulet DH
Eur J Immunol; 2003 Feb; 33(2):381-91. PubMed ID: 12645935
[TBL] [Abstract][Full Text] [Related]
34. NK cell recognition and killing of melanoma cells is controlled by multiple activating receptor-ligand interactions.
Morgado S; Sanchez-Correa B; Casado JG; Duran E; Gayoso I; Labella F; Solana R; Tarazona R
J Innate Immun; 2011; 3(4):365-73. PubMed ID: 21576932
[TBL] [Abstract][Full Text] [Related]
35. Antigen presenting cells and stromal cells trigger human natural killer lymphocytes to autoreactivity: evidence for the involvement of natural cytotoxicity receptors (NCR) and NKG2D.
Poggi A; Zocchi MR
Clin Dev Immunol; 2006; 13(2-4):325-36. PubMed ID: 17162374
[TBL] [Abstract][Full Text] [Related]
36. Expression of natural cytotoxicity receptors and a2V-ATPase on peripheral blood NK cell subsets in women with recurrent spontaneous abortions and implantation failures.
Fukui A; Ntrivalas E; Gilman-Sachs A; Kwak-Kim J; Lee SK; Levine R; Beaman K
Am J Reprod Immunol; 2006; 56(5-6):312-20. PubMed ID: 17076675
[TBL] [Abstract][Full Text] [Related]
37. PGE2 inhibits natural killer and gamma delta T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling.
Martinet L; Jean C; Dietrich G; Fournié JJ; Poupot R
Biochem Pharmacol; 2010 Sep; 80(6):838-45. PubMed ID: 20470757
[TBL] [Abstract][Full Text] [Related]
38. Identification of the amino acid sequence motif for conventional PKC-mediated regulation of NKp46 surface expression.
Kim HR; Chwae YJ; Kim J
Scand J Immunol; 2010 Jun; 71(6):413-9. PubMed ID: 20500693
[TBL] [Abstract][Full Text] [Related]
39. A Duffy binding-like domain is involved in the NKp30-mediated recognition of Plasmodium falciparum-parasitized erythrocytes by natural killer cells.
Mavoungou E; Held J; Mewono L; Kremsner PG
J Infect Dis; 2007 May; 195(10):1521-31. PubMed ID: 17436233
[TBL] [Abstract][Full Text] [Related]
40. Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.
Takayama T; Kamada N; Chinen H; Okamoto S; Kitazume MT; Chang J; Matuzaki Y; Suzuki S; Sugita A; Koganei K; Hisamatsu T; Kanai T; Hibi T
Gastroenterology; 2010 Sep; 139(3):882-92, 892.e1-3. PubMed ID: 20638936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
